Source summary (excerpt): “Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.”
Sourcing: single source, treat as unconfirmed until corroborated.
MarketsBRIEF
Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
CNBC reported on Mon Nov 9, 8:30 AM CT, unconfirmed by other outlets so far: Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval.
What happened
Reported from CNBC. Site-only brief: it was not posted on X.